全文获取类型
收费全文 | 31318篇 |
免费 | 3023篇 |
国内免费 | 2148篇 |
专业分类
耳鼻咽喉 | 231篇 |
儿科学 | 447篇 |
妇产科学 | 375篇 |
基础医学 | 3670篇 |
口腔科学 | 562篇 |
临床医学 | 4147篇 |
内科学 | 4947篇 |
皮肤病学 | 276篇 |
神经病学 | 1563篇 |
特种医学 | 1298篇 |
外国民族医学 | 12篇 |
外科学 | 3675篇 |
综合类 | 4827篇 |
现状与发展 | 6篇 |
一般理论 | 3篇 |
预防医学 | 2019篇 |
眼科学 | 724篇 |
药学 | 3271篇 |
27篇 | |
中国医学 | 1582篇 |
肿瘤学 | 2827篇 |
出版年
2024年 | 78篇 |
2023年 | 402篇 |
2022年 | 965篇 |
2021年 | 1424篇 |
2020年 | 1056篇 |
2019年 | 992篇 |
2018年 | 1012篇 |
2017年 | 953篇 |
2016年 | 979篇 |
2015年 | 1380篇 |
2014年 | 1684篇 |
2013年 | 1549篇 |
2012年 | 2100篇 |
2011年 | 2495篇 |
2010年 | 1578篇 |
2009年 | 1241篇 |
2008年 | 1644篇 |
2007年 | 1713篇 |
2006年 | 1656篇 |
2005年 | 1616篇 |
2004年 | 1251篇 |
2003年 | 1240篇 |
2002年 | 1122篇 |
2001年 | 934篇 |
2000年 | 836篇 |
1999年 | 785篇 |
1998年 | 450篇 |
1997年 | 518篇 |
1996年 | 337篇 |
1995年 | 304篇 |
1994年 | 238篇 |
1993年 | 193篇 |
1992年 | 245篇 |
1991年 | 226篇 |
1990年 | 201篇 |
1989年 | 182篇 |
1988年 | 144篇 |
1987年 | 150篇 |
1986年 | 128篇 |
1985年 | 82篇 |
1984年 | 58篇 |
1983年 | 35篇 |
1982年 | 21篇 |
1981年 | 23篇 |
1980年 | 29篇 |
1979年 | 49篇 |
1978年 | 24篇 |
1976年 | 21篇 |
1975年 | 23篇 |
1974年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
1.
2.
Xiumei Jiang Xiaowei Zhang Patrick Gray Jiwen Zheng Timothy R. Croley Peter P. Fu 《journal of environmental science and health part c-environmental carcinogenesis & ecotoxicology reviews》2019,37(2):116-131
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability. 相似文献
3.
4.
5.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
6.
7.
8.
9.
10.
Matrine,oxymatrine, and compound Kushen injection from the roots of Sophora flavescens: an overview of their anticancer activities 下载免费PDF全文
In the present review, we updated current information on the chemistry, contents, and anticancer properties of matrine (MT), oxymatrine (OMT), and compound Kushen injection (CKI). The anticancer properties were focused on lung, breast, and liver cancer cells because they are most susceptible. Sources of information were from Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, Directory of Open Access Journals (DOAJ), and China National Knowledge Infrastructure (CNKI). Reference was also made on botanical websites, such as Flora of China and World Flora Online. MT and OMT are dominant quinolizidine alkaloids from the roots of Sophora flavescens (Kushen) of the family Fabaceae. Against lung, breast, and liver cancer cells, MT and OMT inhibit cell proliferation; induce cell cycle arrest, apoptosis, and autophagy; restrict angiogenesis; and inhibit cell metastasis, invasion, and migration. The processes involve various molecular targets and signaling pathways. CKI is a traditional Chinese medicine (TCM) composed of root extracts of S. flavescens and Smilax glabra (Baituling) of the family Smilacaceae. With MT and OMT as major components, CKI has been approved for the treatment of cancer in China more than 20 years ago. In recent years, systematic reviews and meta-analysis have been undertaken to evaluate the anticancer effects of CKI. When CKI is used alone and in combination with chemotherapy of western medicine, there is much to be learned concerning their interactions besides their individual and integrated efficacy. Some perspectives of MT, OMT, and CKI are discussed, and their suggestions for future research are provided. 相似文献